Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Company Profile iShares Dow Jones Indust Average UCITS ETF USD A IDOWF

The investment objective of the Fund is to deliver the net total return performance of the Benchmark Index (being the Dow Jones Industrial Average Index), less the fees and expenses of the Fund.

Showcase News Releases

Showcase news

NexTech3D.AI Corp.
Nextech3D.ai Year-End Letter to Shareholders: Positioned for Growth, Profitability, and Innovation in 2025
Voyageur Pharmaceuticals Ltd
Canadian Investment Regulatory Organization Trade Resumption - VM
Voyageur Pharmaceuticals Ltd
Voyageur Pharmaceuticals Ltd. Signs Letter of Intent with Global Contrast Imaging Company to Expand Market Reach and Product Portfolio

More Showcase News Releases »